MedTrace Logo

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

NCT02097277 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2019-07-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the potential of BMS-986036 for treatment obese adults with type-2 diabetes.

Conditions

  • Diabetes Mellitus Type 2

Interventions

BIOLOGICAL

BMS-986036

BIOLOGICAL

Placebo (Matching with BMS-986036)

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-15
Primary Completion
2015-09-22
Completion
2016-05-17

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02097277 on ClinicalTrials.gov